Aptuit beefs up API biz; GVK scandal cast shadow in India;

> Contract manufacturer Aptuit is expanding its API operation in in the U.K. and Italy in response to a surge in demand. Item

> The data manipulation scandal at GVK Biosciences has unduly marred the reputation of Indian clinical trials, an industry group tells Outsourcing-Pharma. More

Suggested Articles

Genesis Drug Discovery & Development has bought up New England Discovery Partners as it looks to boost its synthetic and medicinal chemistry.

Sanofi plans to incorporate its real-world data platform with Aetion’s analytics system to better develop studies for regulatory decision-making.

Major CRO player Pharmaceutical Product Development is set to go back on the public markets after announcing its IPO plans.